104 related articles for article (PubMed ID: 14607390)
1. A quantitative neuromotor predictor of antidepressant non-response in patients with major depression.
Caligiuri MP; Gentili V; Eberson S; Kelsoe J; Rapaport M; Gillin JC
J Affect Disord; 2003 Nov; 77(2):135-41. PubMed ID: 14607390
[TBL] [Abstract][Full Text] [Related]
2. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
3. Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?
Zimmerman M; Posternak MA; Chelminski I
J Nerv Ment Dis; 2005 Mar; 193(3):170-5. PubMed ID: 15729106
[TBL] [Abstract][Full Text] [Related]
4. Sertraline treatment of elderly patients with depression and cognitive impairment.
Devanand DP; Pelton GH; Marston K; Camacho Y; Roose SP; Stern Y; Sackeim HA
Int J Geriatr Psychiatry; 2003 Feb; 18(2):123-30. PubMed ID: 12571820
[TBL] [Abstract][Full Text] [Related]
5. Motor and cognitive aspects of motor retardation in depression.
Caligiuri MP; Ellwanger J
J Affect Disord; 2000; 57(1-3):83-93. PubMed ID: 10708819
[TBL] [Abstract][Full Text] [Related]
6. Predictors of an acute antidepressant response to fluoxetine and sertraline.
Flament MF; Lane RM; Zhu R; Ying Z
Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
[TBL] [Abstract][Full Text] [Related]
7. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
8. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
9. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
Tadić A; Helmreich I; Mergl R; Hautzinger M; Kohnen R; Henkel V; Hegerl U
J Affect Disord; 2010 Jan; 120(1-3):86-93. PubMed ID: 19428118
[TBL] [Abstract][Full Text] [Related]
10. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
[TBL] [Abstract][Full Text] [Related]
11. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.
Krell HV; Leuchter AF; Morgan M; Cook IA; Abrams M
J Clin Psychiatry; 2004 Sep; 65(9):1174-9. PubMed ID: 15367043
[TBL] [Abstract][Full Text] [Related]
12. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
Kavoussi RJ; Segraves RT; Hughes AR; Ascher JA; Johnston JA
J Clin Psychiatry; 1997 Dec; 58(12):532-7. PubMed ID: 9448656
[TBL] [Abstract][Full Text] [Related]
14. Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial.
Mowla A; Dastgheib SA; Razeghian Jahromi L
Clin Drug Investig; 2016 Jul; 36(7):539-43. PubMed ID: 27071759
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
16. Prefrontal dysfunction and treatment response in geriatric depression.
Kalayam B; Alexopoulos GS
Arch Gen Psychiatry; 1999 Aug; 56(8):713-8. PubMed ID: 10435605
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
Kravitz HM; Fogg L; Fawcett J; Edwards J
Psychiatry Res; 1990 May; 32(2):141-9. PubMed ID: 2195576
[TBL] [Abstract][Full Text] [Related]
18. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
19. Valproate as an antidepressant in major depressive disorder.
Davis LL; Kabel D; Patel D; Choate AD; Foslien-Nash C; Gurguis GN; Kramer GL; Petty F
Psychopharmacol Bull; 1996; 32(4):647-52. PubMed ID: 8993086
[TBL] [Abstract][Full Text] [Related]
20. Influence of resistance to antidepressant pharmacotherapy on short-term response to electroconvulsive therapy.
Pluijms EM; Birkenhäger TK; Huijbrechts IP; Moleman P
J Affect Disord; 2002 May; 69(1-3):93-9. PubMed ID: 12103456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
